Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Nichols

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Cancer Research|August 1, 1982
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposureJ N Ingle, S J Green, D L Ahmann, et al.
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of PALA in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|July 1, 1981
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11K L Mohlke, W C Nichols, R J Westrick, et al.
Journal of Medical Genetics|July 13, 2002
Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease familiesW C Nichols, N Pankratz, S K Uniacke, et al.
Cancer Treatment Reports|May 1, 1978
Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapyW C Nichols, L K Kvols, J N Ingle, et al.
Cancer Treatment Reports|October 1, 1980
Phase II evaluation of triazinate in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|November 1, 1981
Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
The Journal of Clinical Investigation|February 15, 1997
Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mappingW C Nichols, U Seligsohn, A Zivelin, et al.
Neurology|May 12, 2004
Genes influencing Parkinson disease onset: replication of PARK3 and identification of novel lociN Pankratz, S K Uniacke, C A Halter, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Cancer Research|August 1, 1982
Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposureJ N Ingle, S J Green, D L Ahmann, et al.
Cancer Treatment Reports|March 1, 1981
Phase II evaluation of PALA in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|July 1, 1981
Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 24, 1996
A novel modifier gene for plasma von Willebrand factor level maps to distal mouse chromosome 11K L Mohlke, W C Nichols, R J Westrick, et al.
Journal of Medical Genetics|July 13, 2002
Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease familiesW C Nichols, N Pankratz, S K Uniacke, et al.
Cancer Treatment Reports|May 1, 1978
Phase II study of triazinate and pyrazofurin in patients with advanced breast cancer previously exposed to cytotoxic chemotherapyW C Nichols, L K Kvols, J N Ingle, et al.
Cancer Treatment Reports|October 1, 1980
Phase II evaluation of triazinate in patients with metastatic lung cancerE T Creagan, R T Eagan, T R Fleming, et al.
Cancer Treatment Reports|November 1, 1981
Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancerR T Eagan, S Frytak, W C Nichols, et al.
The Journal of Clinical Investigation|February 15, 1997
Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mappingW C Nichols, U Seligsohn, A Zivelin, et al.
Neurology|May 12, 2004
Genes influencing Parkinson disease onset: replication of PARK3 and identification of novel lociN Pankratz, S K Uniacke, C A Halter, et al.
Pageof 8